Company: SXTPW
Filing Date: 2025-02-06
Form Type: 8-K
Source: 0001213900-25-010962
Chunk: 0

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-02-06
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01 Entry into a Material Definitive
Agreement.

On February 5, 2025,
60 Degrees Pharmaceuticals, Inc., a Delaware corporation (the “ Company”), entered into a securities purchase agreement (the
“ Securities Purchase Agreement”) with certain institutional investors (the “ Purchasers”) pursuant to which the
Company sold, in a registered direct offering an aggregate of 1,503,500 shares (the “ Shares”) of common stock, par value $0.0001
per share, of the Company (“ Common Stock”) at a purchase price of $0.715 per share in a registered direct offering priced
at-the-market under the rules of The Nasdaq Stock Market LLC.

The Shares were offered
pursuant to a “shelf” registration statement on Form S-3 (Registration No. 333-280796), which was declared effective by the
Securities and Exchange Commission (the “ SEC”) on July 18, 2024 as supplemented by a prospectus supplement dated February
5, 2025, filed with the SEC on February 6, 2025, and accompanying base prospectus, pursuant to Rule 424(b)(5) promulgated under the Securities
Act of 1933, as amended (the “ Securities Act”).

In a concurrent private placement, the Company
also issued to the Purchasers unregistered warrants (the “ Warrants”) to purchase up to an aggregate of 1,503,500 shares (the
“ Warrant Shares”) of Common Stock at an exercise price of $0.59 per share. The Warrants are exercisable upon issuance and
expire twenty-four months from the date of issuance.

Pursuant to the Securities
Purchase Agreement, the Company is required to file a registration statement with the SEC within 45 days after the date of the Securities
Purchase Agreement to register the Warrant Shares under the Securities Act. The Company shall use commercially reasonable efforts to cause
such registration statement to become effective within 75 days following the Closing Date and to keep such registration statement effective
at all times until no Purchaser owns any Warrants or Warrant Shares issuable upon exercise thereof.

Any holder will not have the right to exercise
any portion of the Warrants if the holder (together with its affiliates) would beneficially own more than 4.99% (or, upon the election
of the holder, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving